Abstract
Background: Thyroid gland is highly dependent on dietary intake of iodine for normal function, so it is particularly subjected to “endocrine disruptor” action. The human sodium/iodide symporter (hNIS) is an integral plasma membrane glycoprotein mediating the active transport of iodide into thyroid follicular cells, a crucial step for thyroid hormone biosynthesis. Beyond to perchlorate and thyocianate ions a few other inhibitors of iodide uptake have been described. Aim: The aim of this study was to investigate if 10 substances usually used as drugs in clinical practice were able to inhibit NIS-mediated iodide uptake in vitro. Materials and methods: A CHO cell line stably expressing hNIS was used to test any inhibition of NIS-mediated iodide uptake exerted by drugs. Perchlorate and thyocianate ions were used as positive controls. Results: None of the analyzed substances was able to significantly inhibit iodide uptake in our system. As we expected, perchlorate and thyocianate ions were able to inhibit iodide uptake in a dose-dependent manner. Conclusions: In conclusion, we carried out an in vitro assay to evaluate the potential inhibitory effect of common drugs on NIS-mediated iodide uptake by using CHO-hNIS cells. None of the analyzed substances was able to inhibit iodide uptake; only perchlorate and thyocianate were able to inhibit iodide uptake in a dose-dependent manner.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Brucker-Davis F. Effects of environmental synthetic chemicals on thyroid function. Thyroid 1998, 8: 827–56.
Zacharewski T. Identification and assessment of endocrine disruptors: limitations of in vivo and in vitro assays. Environ Health Perspect 1998, 2: 577–82.
Colborn T. Clues from wildlife to create an assay for thyroid system disruption. Environ Health Perspect 2002, 110(Suppl 3): 363–7.
Levy O, De La Vieja A, Carrasco N. The Na + I-symporter (NIS): recent advances. J Bioenerg Biomembr 1998, 30: 195–206.
Dohan O, De La Vieja A, Paroder V, et al. The sodium/iodide symporter (NIS): characterization, regulation and medical significance. Endocr Rev 2003, 24: 48–77.
Wolff J. Transport of iodide and other anions in the thyroid gland. Physiol Rev 1964, 44: 45–90.
Kaminsky SM, Levy O, Garry MT, Carrasco N. Inhibition of the Na+/I-symporter by harmaline and 3-amino-1-methyl-5H-pyridol(3,4-b)indole acetate in thyroid cells and membrane vesicles. Eur J Biochem 1991, 200: 203–7.
Van Sande J, Deneubourg F, Beauwens R, Braekman JC, Daloze D, Dumont JE. Inhibition of iodide transportin thyroid cells by dysidenin, a marine toxin, and some of its analogs. Mol Pharmacol 1990, 37: 583–9.
Gerard C, Rigot V, Penel C. Cholride channel blockers inhibit the Na+/I-symporter in thyroid follicles in culture. Biochem Biophys Res Commun 1994, 204: 1265–71.
Cook JS, Shaffer C, Cragoe EJ Jr. Inhibition by amiloride analogues of Na-dependent hexose uptake in LLC-PK1/Cl4 cells. Am J Physiol 1987, 253: 199–204.
Vroye L, Beauwens R, Van Sande J, Daloze D, Braekman JC, Golstein PE. The Na+-I-cotransporter of the thyroid: characterisation of newinhibitors. Eur J Physiol 1998, 435: 259–66.
McManus M, Serhan C, Jackson P, Strange K. Ketoconazole blocks organic osmolyte effluxindependently of its effect on arachidonic acid conversion. Am J Physiol 1994, 267: C266–71.
Tonacchera M, Agretti P, Ceccarini G, et al. Autoantibodies from patients with autoimmune thyroid disease do not interfere with the activity of the human iodide symporter gene stably transfected in CHO cells. Eur J Endocrinol 2001, 144: 611–8.
Gaitan E. Iodine sufficient goiter and autoimmune thyroiditis: the Kentucky and Columbian experience. In: Medeiros-Neto G, Gaitan E (eds). Frontiers in thyroidology. Volume 1. New York: Plenum Press. 1986, 19–25.
Vought RL, London WT, Stebbing GE. Endemic goiter in Northern Virginia. J Clin Endocrinol 1967, 27: 1381–9.
Beierwaltes WH. Themostcommon thyroid disease in the state of Michigan is endemic goiter not due to iodine deficiency. Washt County Med Soc Bull 1987, 39: 3–10.
Wingren G, Hatschek T, Axelson O. Determinants of papillary cancer of the thyroid. Am J Epidemiol 1993, 138: 482–91.
Kohrle J. Flavonoids as a risk factor for goiter and hypothyroidism. In Péter F, Wiersinga W, Hostalek U (eds). The thyroid and environment, Merk European Thyroid Symposium. Stuttgart: Schattauer. 2000, 41–63.
Gaitan E. Environmental natural goitrogens. In Péter F, Wiersinga W, Hostalek U eds. The thyroid and environment, Merk European Thyroid Symposium. Stuttgart: Schattauer. 2000, 69–78.
Zoeller RT. Environmental chemicals as thyroid hormone analogues: new studies indicate that thyroid hormone receptors are targets of industrial chemicals? Mol Cell Endocrinol 2005, 242: 10–5.
Santini F, Vitti P, Ceccarini G, et al. In vitro assay of thyroid disruptors affecting TSH-stimulated adenylate cyclase activity. J Endocrinol Invest 2003, 26: 950–5.
Dixon M, Webb EC (eds). Enzyme inhibition and activation. In: Enzymes, vol. VIII: enzyme inhibition and activation. London: Longman Group Limited. 1979, 332–468.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Agretti, P., Dimida, A., De Marco, G. et al. Study of potential inhibitors of thyroid iodide uptake by using CHO cells stably expressing the human sodium/iodide symporter (hNIS) protein. J Endocrinol Invest 34, 170–174 (2011). https://doi.org/10.1007/BF03347061
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03347061